6-Month aortic valve implantation of an off-the-shelf tissue-engineered valve in sheep

Biomaterials

Volumn 73, Issue , 2015, Pages 175-184

  Syedain, Zeeshan ^a   Reimer, Jay ^a   Schmidt, Jillian ^a   Lahti, Matthew ^b   Berry, James ^b   Bianco, Richard ^b   Tranquillo, Robert T ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Aortic valve disease; Decellualrized biomaterial; Heart valve; Matrix remodeling; Tissue engineering

Indexed keywords

BIOMECHANICS; BIOMINERALIZATION; BLOOD VESSELS; HIGH PRESSURE ENGINEERING; ORIFICES; POLYMERIC IMPLANTS; PRESSURE GRADIENT; SCAFFOLDS (BIOLOGY); TISSUE; TISSUE ENGINEERING;

AORTIC VALVE LEAFLETS; AORTIC VALVES; EFFECTIVE ORIFICE AREAS; EXTRACELLULAR MATRIX DEPOSITION; HEART VALVES; HIGH-PRESSURE GRADIENT; MATRIX REMODELING; TENSILE MECHANICAL PROPERTIES;

VALVES (MECHANICAL);

BIOMATERIAL; COLLAGEN; ELASTIN; FIBRIN; POLYMER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA VALVE DISEASE; AORTIC VALVE IMPLANTATION; ARTICLE; BIOMECHANICS; CONTROLLED STUDY; DNA DETERMINATION; HEMODYNAMICS; HISTOLOGY; HUMAN; HUMAN CELL; IMPLANTATION; NONHUMAN; PRIORITY JOURNAL; SHEEP; SYSTOLIC BLOOD PRESSURE; TISSUE ENGINEERING; ANIMAL; AORTA VALVE; BIOPROSTHESIS; CHEMISTRY; DEVICES; EXTRACELLULAR MATRIX; FIBROBLAST; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; MECHANICAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PROCEDURES; PROSTHESIS DESIGN; SKIN; TENSILE STRENGTH; TIME FACTOR;

ANIMALS; AORTIC VALVE; BIOCOMPATIBLE MATERIALS; BIOPROSTHESIS; COLLAGEN; EXTRACELLULAR MATRIX; FIBRIN; FIBROBLASTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEMODYNAMICS; HUMANS; POLYMERS; PROSTHESIS DESIGN; SHEEP; SKIN; STRESS, MECHANICAL; TENSILE STRENGTH; TIME FACTORS; TISSUE ENGINEERING;

EID: 84943577525     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2015.09.016     Document Type: Article

References (31)

1. HCUP. Healthcare Cost and Utilization Project's National InPatient Sample 2014, http://www.hcup-us.ahrq.gov/databases.jsp.
2. Baraki H., Tudorache I., Braun M., Hoffler K., Gorler A., Lichtenberg A., Bara C., Calistru A., Brandes G., Hewicker-Trautwein M., Hilfiker A., Haverich A., Cebotari S. Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials 2009, 30:6240-6246.
3. Tudorache I., Calistru A., Baraki H., Meyer T., Hoffler K., Sarikouch S., Bara C., Gorler A., Hartung D., Hilfiker A., Haverich A., Cebotari S. Orthotopic replacement of aortic heart valves with tissue-engineered grafts. Tissue Eng. Part A 2013, 19:1686-1694.
4. Della Barbera M., Valente M., Basso C., Thiene G. Morphologic studies of cell endogenous repopulation in decellularized aortic and pulmonary homografts implanted in sheep. Cardiovasc. Pathol. 2015, 24:102-109.
5. Honge J.L., Funder J., Hansen E., Dohmen P.M., Konertz W., Hasenkam J.M. Recellularization of aortic valves in pigs. Eur. J. Cardiothorac. Surg. 2011, 39:829-834.
6. Akhyari P., Kamiya H., Gwanmesia P., Aubin H., Tschierschke R., Hoffmann S., Karck M., Lichtenberg A. In vivo functional performance and structural maturation of decellularised allogenic aortic valves in the subcoronary position. Eur. J. Cardiothorac. Surg. 2010, 38:539-546.
7. Tudorache I., Horke A., Sarikouch S., Ciubotaru A., Breymann T., Boethig D., Beerbaum P., Bertram H., Westhoff-Bleck M., Meschenmoser L., Cebotari S., Haverich A. Abstract 19959: aortic valve replacement with decellularized aortic allografts: first clinical results. Circulation 2014, 130:A19959.
8. Driessen-Mol A., Emmert M.Y., Dijkman P.E., Frese L., Sanders B., Weber B., Cesarovic N., Sidler M., Leenders J., Jenni R., Grunenfelder J., Falk V., Baaijens F.P., Hoerstrup S.P. Transcatheter implantation of homologous "off-the-shelf" tissue-engineered heart valves with self-repair capacity: long-term functionality and rapid in vivo remodeling in sheep. J. Am. Coll. Cardiol. 2014, 63:1320-1329.
9. Weber B., Dijkman P.E., Scherman J., Sanders B., Emmert M.Y., Grunenfelder J., Verbeek R., Bracher M., Black M., Franz T., Kortsmit J., Modregger P., Peter S., Stampanoni M., Robert J., Kehl D., van Doeselaar M., Schweiger M., Brokopp C.E., Walchli T., Falk V., Zilla P., Driessen-Mol A., Baaijens F.P., Hoerstrup S.P. Off-the-shelf human decellularized tissue-engineered heart valves in a non-human primate model. Biomaterials 2013, 34:7269-7280.
10. Flanagan T.C., Sachweh J.S., Frese J., Schnoring H., Gronloh N., Koch S., Tolba R.H., Schmitz-Rode T., Jockenhoevel S. In vivo remodeling and structural characterization of fibrin-based tissue-engineered heart valves in the adult sheep model. Tissue Eng. Part A 2009, 15:2965-2976.
11. Syedain Z.H., Lahti M., Johnson S.L., Robinson P.S., Ruth G.R., Bianco R.W., Tranquillo R.T. Implantation of a tissue-engineered heart valve from human fibroblasts exhibiting short term function in the sheep pulmonary artery. Cardiovasc. Eng. Technol. 2011, 2:101-112.
12. Gottlieb D., Kunal T., Emani S., Aikawa E., Brown D.W., Powell A.J., Nedder A., Engelmayr G.C., Melero-Martin J.M., Sacks M.S., Mayer J.E. In vivo monitoring of function of autologous engineered pulmonary valve. J. Thorac. Cardiovasc Surg. 2010, 139:723-731.
13. Emmert M.Y., Weber B., Wolint P., Behr L., Sammut S., Frauenfelder T., Frese L., Scherman J., Brokopp C.E., Templin C., Grunenfelder J., Zund G., Falk V., Hoerstrup S.P. Stem cell-based transcatheter aortic valve implantation: first experiences in a pre-clinical model. JACC Cardiovasc. Interv. 2012, 5:874-883.
14. Syedain Z.H., Meier L.A., Lahti M.T., Johnson S.L., Tranquillo R.T. Implantation of completely biological engineered grafts following decellularization into the sheep femoral artery. Tissue Eng. Part A 2014, 20:1726-1734.
15. Meier L.A., Syedain Z.H., Lahti M.T., Johnson S.S., Chen M.H., Hebbel R.P., Tranquillo R.T. Blood outgrowth endothelial cells alter remodeling of completely biological engineered grafts implanted into the sheep femoral artery. J. Cardiovasc. Transl. Res. 2014, 7:242-249.
16. Syedain Z.H., Meier L.A., Reimer J.M., Tranquillo R.T. Tubular heart valves from decellularized engineered tissue. Ann. Biomed. Eng. 2013, 41:2645-2654.
17. Dijkman P.E., Driessen-Mol A., de Heer L.M., Kluin J., van Herwerden L.A., Odermatt B., Baaijens F.P., Hoerstrup S.P. Trans-apical versus surgical implantation of autologous ovine tissue-engineered heart valves. J. Heart Valve Dis. 2012, 21:670-678.
18. Emmert M.Y., Weber B., Wolint P., Behr L., Sammut S., Frauenfelder T., Frese L., Scherman J., Brokopp C.E., Templin C., Grunenfelder J., Zund G., Falk V., Hoerstrup S.P. Stem cell-based transcatheter aortic valve implantation: first experiences in a pre-clinical model. JACC Cardiovasc Interv. 2012, 5:874-883.
19. Syedain Z.H., Meier L.A., Bjork J.W., Lee A., Tranquillo R.T. Implantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 2011, 32:714-722.
20. ISO-5840 Cardiovascular Implant - Cardiac Valve Prostheses. Cardiovascular Implant - Cardiac Valve Prostheses 2010.
21. Stegemann H., Stalder K. Determination of hydroxyproline. Clin. Chim. Acta 1967, 18:267-273.
22. Robinson P.S., Johnson S.L., Evans M.C., Barocas V.H., Tranquillo R.T. Functional tissue-engineered valves from cell-remodeled fibrin with commissural alignment of cell-produced collagen. Tissue Eng. Part A 2008, 14:83-95.
23. Kim Y.J., Sah R.L., Doong J.Y., Grodzinsky A.J. Fluorometric assay of DNA in cartilage explants using Hoechst 33258. Anal. Biochem. 1988, 174:168-176.
24. Kaneko T., Aranki S., Javed Q., McGurk S., Shekar P., Davidson M., Cohn L. Mechanical versus bioprosthetic mitral valve replacement in patients <65 years old. J. Thorac. Cardiovasc Surg. 2014, 147:117-126.
25. Saleeb S.F., Newburger J.W., Geva T., Baird C.W., Gauvreau K., Padera R.F., Del Nido P.J., Borisuk M.J., Sanders S.P., Mayer J.E. Accelerated degeneration of a bovine pericardial bioprosthetic aortic valve in children and young adults. Circulation 2014, 130:51-60.
26. Aikawa E., Whittaker P., Farber M., Mendelson K., Padera R.F., Aikawa M., Schoen F.J. Human semilunar cardiac valve remodeling by activated cells from fetus to adult: implications for postnatal adaptation, pathology, and tissue engineering. Circulation 2006, 113:1344-1352.
27. Perri G., Polito A., Esposito C., Albanese S.B., Francalanci P., Pongiglione G., Carotti A. Early and late failure of tissue-engineered pulmonary valve conduits used for right ventricular outflow tract reconstruction in patients with congenital heart disease. Eur. J. Cardiothorac. Surg. 2012, 41:1320-1325.
28. Neumann A., Cebotari S., Tudorache I., Haverich A., Sarikouch S. Heart valve engineering: decellularized allograft matrices in clinical practice. Biomed. Tech. Berl. 2013, 58:453-456.
29. da Costa F.D., Costa A.C., Prestes R., Domanski A.C., Balbi E.M., Ferreira A.D., Lopes S.V. The early and midterm function of decellularized aortic valve allografts. Ann. Thorac. Surg. 2010, 90:1854-1860.
30. Syedain Z.H., Bradee A.R., Kren S., Taylor D.A., Tranquillo R.T. Decellularized tissue-engineered heart valve leaflets with recellularization potential. Tissue Eng. Part A 2013, 19:759-769.
31. Weidenhamer N.K., Moore D.L., Lobo F.L., Klair N.T., Tranquillo R.T. Influence of culture conditions and extracellular matrix alignment on human mesenchymal stem cells invasion into decellularized engineered tissues. J. Tissue Eng. Regen. Med. 2015, 9(5):605-618.